Samantha Truex

Samantha Truex is CEO of Upstream Bio. Sam has served in leadership roles at multiple venture-backed companies including as CEO of Quench Bio, COO of Synlogic, and CBO for Padlock Therapeutics. Previously, Sam was Vice President of Corporate Development at Biogen where she led transactional business development activities and served as program executive for now-marketed products FAMPYRA,® ELOCTATE™, and ALPROLIX™. Sam also previously worked in Corporate Development at Genzyme, Chiron Diagnostics, and Health Advances. Sam earned a BA in biology from Dartmouth College, a BE in biomedical engineering from the Thayer School at Dartmouth, and an MBA from the Tuck School at Dartmouth. Sam is also on the boards of Thayer School of Engineering at Dartmouth and Life Science Cares.